News

AbbVie (ABBV) reported better-than-expected fourth-quarter results on Friday amid robust sales of Skyrizi and Rinvoq ... to ...
AbbVie stock retook its 200-day moving average Friday after the company raised its long-term outlook for immunology powerhouses Skyrizi and Rinvoq by $4 billion. The company now projects more than ...
AbbVie ran its new eczema TV ad for Rinvoq this month, too, though it had a very different feel. In the commercial, dubbed "Helicopter," the viewer instantly feels like they have been dropped in a ...
The commercial is clearly branded with the Cibinqo ... that will go to the wild ride that has been ads for AbbVie’s rival therapy Rinvoq, which have featured extreme sports and dashes to ...
Our optimism arises from Skyrizi's/Rinvoq's promising double-digit growth, excellent ex-Humira portfolio sales growth, and the management's raised FY2024/FY2027 guidance. ABBV's balance sheet ...
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of AbbVie's upadacitinib (Rinvoq) to treat adults with giant cell arteritis (GCA).
Jan 10 (Reuters) - AbbVie Inc (ABBV.N), opens new tab on Tuesday raised its 2025 sales forecast of its newer immunology drugs Skyrizi and Rinvoq to more than $17.5 billion as it hopes to replace ...
Rinvoq is back as the lead Rx and over-the-counter (OTC ... pharma advertisers continued to gravitate toward news broadcasts and live sports, running commercials during both the men’s and women’s ...
AbbVie executives say the company’s immunology drugs Skyrizi and Rinvoq are expanding their reach in the inflammatory bowel disease (IBD) as the market for Humira biosimilars heats up.
April 25 (Reuters) - AbbVie (ABBV.N), opens new tab said on Thursday its drug, Rinvoq, for treating a type of inflammatory skin condition was found to be more effective than Regeneron ...
No new safety signals for Rinvoq were observed. Rinvoq showed long-term efficacy and safety up to 140 weeks in the treatment of moderate to severe atopic dermatitis in adults and adolescents aged ...
Taking a break from politics, I am curious about medications I’ve seen advertised, some of which are Xyzal, Sotykto, Wegovy, Rinvoq, Skyrizi, Dupixent, Dovato, Verzenio, Zyrtec, Vyvgart ...